1. Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting System. Issue 9 (September 2019) Authors: Mohamoud, Mohamed; Patanavanich, Saharat; Crew, Page; McCulley, Lynda; Munoz, Monica; Kortepeter, Cindy; Jones, S. Christopher; Woronow, Daniel; Dal Pan, Gerald Journal: Annals of pharmacotherapy Issue: Volume 53:Issue 9(2019) Page Start: 962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Harmful effects of chlorine dioxide exposure. (4th May 2021) Authors: Lardieri, Allison; Cheng, Carmen; Jones, S. Christopher; McCulley, Lynda Journal: Clinical toxicology Issue: Volume 59:Number 5(2021) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System. Issue 4 (19th January 2022) Authors: Dores, Graça M.; Nayernama, Afrouz; Cheng, Connie; Moureaud, Charlotte; Jones, S. Christopher Journal: American journal of hematology Issue: Volume 97:Issue 4(2022) Page Start: E129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System. Issue 12 (2nd December 2018) Authors: Cheng, Connie; Woronow, Daniel; Nayernama, Afrouz; Wroblewski, Tanya; Jones, S. Christopher Journal: Leukemia & lymphoma Issue: Volume 59:Issue 12(2018) Page Start: 3016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ibrutinib‐associated Pneumocystis jirovecii pneumonia. Issue 11 (28th September 2017) Authors: Lee, Regina; Nayernama, Afrouz; Jones, S. Christopher; Wroblewski, Tanya; Waldron, Peter E. Journal: American journal of hematology Issue: Volume 92:Issue 11(2017:Nov.) Page Start: E646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature. Issue 9 (29th April 2020) Authors: Nguyen, Michelle Nadeau; Nayernama, Afrouz; Jones, S. Christopher; Kanapuru, Bindu; Gormley, Nicole; Waldron, Peter E. Journal: American journal of hematology Issue: Volume 95:Issue 9(2020:Sep.) Page Start: E218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Unusual Neisseria species as a cause of infection in patients taking eculizumab. Issue 2 (February 2019) Authors: Crew, Page E.; McNamara, Lucy; Waldron, Peter E.; McCulley, Lynda; Jones, S. Christopher; Bersoff-Matcha, Susan J. Journal: Journal of infection Issue: Volume 78:Issue 2(2019) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data†. (28th May 2014) Authors: Houstoun, Monika; Reichman, Marsha E.; Graham, David J.; Nambiar, Sumathi; Shamsuddin, Hala; Jones, S. Christopher; Cao, Kelly; Wernecke, Michael; Lam, Chelsea; Worrall, Chris M.; MaCurdy, Thomas E.; Kelman, Jeffrey A. Journal: Pharmacoepidemiology and drug safety Issue: Volume 23:Number 9(2014:Sep.) Page Start: 911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. US‐based emergency department visits for fluoroquinolone‐associated hypersensitivity reactions. (20th August 2013) Authors: Jones, S. Christopher; Budnitz, Daniel S.; Sorbello, Alfred; Mehta, Hina Journal: Pharmacoepidemiology and drug safety Issue: Volume 22:Number 10(2013:Oct.) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗